Gene-editing techniques such as CRISPR-Cas are improving rapidly, opening the path toward their more frequent therapeutic use. Yet, no matter how good these techniques become, off-target errors are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback